Personal information

Verified email domains

natural killer cells, NK cells, natural killer cell development, immunology, cell biology, innate immunology
United States

Activities

Employment (2)

ImmuneBridge,Inc: San Francisco, CA, US

2024-02-14 to present
Employment
Source: Self-asserted source
Everardo Hegewisch-Solloa

Columbia University Irving Medical Center: New York, US

2023-11-20 to present | Postdoctoral Researcher (Department of Pediatrics)
Employment
Source: Self-asserted source
Everardo Hegewisch-Solloa

Education and qualifications (5)

Columbia University Irving Medical Center: New York, NY, US

2018-08-01 to 2023-11-15 | PhD (Cellular, Molecular, and Biomedical Studies)
Education
Source: Self-asserted source
Everardo Hegewisch-Solloa

Columbia University Irving Medical Center: New York, NY, US

2018 to 2021 | MPh. (Integrated Program in Cellular, Molecular, and Biomedical Studies)
Education
Source: Self-asserted source
Everardo Hegewisch-Solloa

Columbia University Irving Medical Center: New York, NY, US

2018 to 2020 | M.A. (Integrated Program in Cellular, Molecular, and Biomedical Studies)
Education
Source: Self-asserted source
Everardo Hegewisch-Solloa

University of California, San Diego: San Diego, California, US

2017-09-15 to 2018-06-15 | MSc (Biological Sciences)
Education
Source: Self-asserted source
Everardo Hegewisch-Solloa

University of California, San Diego: San Diego, California, US

2015-09-15 to 2017-06-17 | BS Microbiology (Biological Sciences)
Education
Source: Self-asserted source
Everardo Hegewisch-Solloa

Professional activities (5)

Columbia University Irving Medical Center: New York, US

2023-09 to present | Herbert Irving Comprehensive Cancer Center Trainee Associate Member
Membership
Source: Self-asserted source
Everardo Hegewisch-Solloa

Columbia University Irving Medical Center: New York, US

2023-07 to present | Columbia Stem Cell Initiative Work In-Progress committee member
Membership
Source: Self-asserted source
Everardo Hegewisch-Solloa

Society for Natural Immunity NK2023: Oslo, NO

2023-09 | Travel Award
Distinction
Source: Self-asserted source
Everardo Hegewisch-Solloa

Columbia University Irving Medical Center: New York, US

2023-05-22 | the Oberfield Prize in Pre-doctoral Science (Department of Pediatrics)
Distinction
Source: Self-asserted source
Everardo Hegewisch-Solloa

Society for Natural Immunity NK2022: Bonita Springs, US

2022-05 | Travel and Poster Award
Distinction
Source: Self-asserted source
Everardo Hegewisch-Solloa

Funding (3)

Contact-dependent determinants of human natural killer cell development

2021-09-01 to 2024-08-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: F31AI164869
Source: Self-asserted source
Everardo Hegewisch-Solloa via DimensionsWizard

Training in Cellular, Molecular and Biomedical Studies

2018-08 to 2019-08 | Award
National Institute of Allergy and Infectious Diseases (Md., Md., US)
GRANT_NUMBER:

T32-GM008224-32

Source: Self-asserted source
Everardo Hegewisch-Solloa

Defining the Role of Cell Migration In Human NK Cell Differentiation

Grant
National Institute of Allergy and Infectious Diseases (Md., Md., US)
Part of GRANT_NUMBER:

3R01AI137073 - 02W1

GRANT_NUMBER:

1R01AI137073

Source: Self-asserted source
Everardo Hegewisch-Solloa

Works (13)

Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations

2024-10-11 | Preprint
Contributors: Hanane Touil; Tain Luquez; Natacha Comandante-Lou; Annie J Lee; Masashi Fujita; Christian Habeck; Alex Kroshilina; Everardo Hegewisch-Solloa; Julie McInvale; Leah Zuroff et al.
Source: check_circle
Crossref

iPSC-based modeling of helicase deficiency reveals impaired cell proliferation and increased apoptosis after NK cell lineage commitment

2023-09-25 | Preprint
Contributors: Seungmae Seo; Sagar L. Patil; Yong-Oon Ahn; Jacqueline Armetta; Everardo Hegewisch-Solloa; Micah Castillo; Nicole C. Guilz; Achchhe Patel; Barbara Corneo; Malgorzata Borowiak et al.
Source: check_circle
Crossref

Mapping human natural killer cell development in pediatric tonsil by imaging mass cytometry and high-resolution microscopy

2023-09-06 | Preprint
Contributors: Everardo Hegewisch-Solloa; Janine E. Melsen; Hiranmayi Ravichandran; André F. Rendeiro; Aharon G. Freud; Bethany Mundy-Bosse; Johannes C. Melms; Shira E. Eisman; Benjamin Izar; Eli Grunstein et al.
Source: check_circle
Crossref

Comparative transcriptomics of porcine liver-resident CD8αdim, liver CD8αhigh and circulating blood CD8αhigh NK cells reveals an intermediate phenotype of liver CD8αhigh NK cells

Frontiers in Immunology
2023-08-18 | Journal article
Part of ISSN: 1664-3224
Contributors: Leen Hermans; Sofie Denaeghel; Robert J. J. Jansens; Steffi De Pelsmaeker; Filip Van Nieuwerburgh; Dieter Deforce; Everardo Hegewisch-Solloa; Emily M. Mace; Eric Cox; Bert Devriendt et al.
Source: Self-asserted source
Everardo Hegewisch-Solloa

Deciphering the localization and trajectory of human natural killer cell development

Journal of Leukocyte Biology
2023-03-04 | Journal article
Part of ISSN: 1938-3673
Contributors: Everardo Hegewisch-Solloa; Ansel P Nalin; Aharon G Freud; Emily Mace
Source: Self-asserted source
Everardo Hegewisch-Solloa

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

Cancer cell
2022-09-01 | Journal article
Contributors: Everardo Hegewisch-Solloa
Source: Self-asserted source
Everardo Hegewisch-Solloa

Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.

Blood cancer discovery
2022-03-01 | Journal article
Contributors: Everardo Hegewisch-Solloa
Source: Self-asserted source
Everardo Hegewisch-Solloa

Quantifying Human Natural Killer Cell Migration by Imaging and Image Analysis.

Methods in molecular biology (Clifton, N.J.)
2022-01-01 | Journal article
Contributors: Everardo Hegewisch-Solloa
Source: Self-asserted source
Everardo Hegewisch-Solloa
grade
Preferred source (of 2)‎

Differential Integrin Adhesome Expression Defines Human NK Cell Residency and Developmental Stage

The Journal of Immunology
2021-08-01 | Journal article
Part of ISSN: 0022-1767
Part of ISSN: 1550-6606
Source: Self-asserted source
Everardo Hegewisch-Solloa

CD56 regulates human NK cell cytotoxicity through Pyk2.

eLife
2020-06-08 | Journal article
Source: Self-asserted source
Everardo Hegewisch-Solloa

Generation of cell-derived matrices that support human NK cell migration and differentiation.

Journal of leukocyte biology
2020-05-11 | Journal article
Source: Self-asserted source
Everardo Hegewisch-Solloa

Defining novel populations of circulation NK cells in human GATA2 deficiency.

Journal of clinical immunology
2020-04-01 | Journal article
Source: Self-asserted source
Everardo Hegewisch-Solloa

Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing.

Blood advances
2020-04-01 | Journal article
Source: Self-asserted source
Everardo Hegewisch-Solloa

Peer review (1 review for 1 publication/grant)

Review activity for Journal of leukocyte biology. (1)